Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

BACKGROUND: Aberrant expression of the RON receptor tyrosine kinase is a pathogenic feature and a validated drug target in various types of cancers. Currently, therapeutic antibodies targeting RON for cancer therapy are under intensive evaluation. Here we report the development and validation of a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Hang-Ping, Feng, Liang, Suthe, Sreedhar Reddy, Chen, Ling-Hui, Weng, Tian-Hao, Hu, Chen-Yu, Jun, Eun Sung, Wu, Zhi-Gang, Wang, Wei-Lin, Kim, Song Cheol, Tong, Xiang-Min, Wang, Ming-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419354/
https://www.ncbi.nlm.nih.gov/pubmed/30871619
http://dx.doi.org/10.1186/s40425-019-0525-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419354/
https://www.ncbi.nlm.nih.gov/pubmed/30871619
http://dx.doi.org/10.1186/s40425-019-0525-0

Ejemplares similares